Home Run
Healthcare
Home Run
Gilead Sciences is an international biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in various sectors. In 2017, it made headlines worldwide for its acquisition of Kite, a biopharmaceutical company engaged in the development of innovative cancer immunotherapies.